Review



34000301 pcad cell signaling  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc 34000301 pcad cell signaling
    34000301 Pcad Cell Signaling, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 25 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/34000301 pcad cell signaling/product/Cell Signaling Technology Inc
    Average 93 stars, based on 25 article reviews
    34000301 pcad cell signaling - by Bioz Stars, 2026-04
    93/100 stars

    Images



    Similar Products

    99
    R&D Systems goat anti pcad
    Goat Anti Pcad, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti pcad/product/R&D Systems
    Average 99 stars, based on 1 article reviews
    goat anti pcad - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    90
    Novus Biologicals pcad antibody
    Pcad Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pcad antibody/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    pcad antibody - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    93
    Addgene inc ppgk1 pcad ires puror wpre
    Ppgk1 Pcad Ires Puror Wpre, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ppgk1 pcad ires puror wpre/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    ppgk1 pcad ires puror wpre - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    93
    Addgene inc recombinant dna ppgk1 pcad ires puror wpre
    Recombinant Dna Ppgk1 Pcad Ires Puror Wpre, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant dna ppgk1 pcad ires puror wpre/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    recombinant dna ppgk1 pcad ires puror wpre - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology anti pcad antibody
    Anti Pcad Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti pcad antibody/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    anti pcad antibody - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    90
    Chemie GmbH pcad enol-lactonase
    Pcad Enol Lactonase, supplied by Chemie GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pcad enol-lactonase/product/Chemie GmbH
    Average 90 stars, based on 1 article reviews
    pcad enol-lactonase - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Millipore anti-pcad
    (A) A schematic outlining the strategy for the identification of a lead <t>pCAD</t> <t>x</t> <t>CDH17</t> BsAb. The first phase involves screening CDH17 monovalent and bivalent antibodies, and pairing the most avid CDH17 arm with a pCAD arm to evaluate potency and binding. The second phase involves screening a panel of pCAD alanine variants to identify the most avid pCAD arm, followed by pairing with the lead CDH17 arm. (B) One-armed antibody (OAA, monovalent) vs full-length antibody (FL, bivalent) internalization and growth inhibition results for the panel of CDH17 candidates in Snu16 and HT29 CDH17+ cell lines. A red dot indicates the top 7 CDH17 candidates. (C) The IC 50 fold changes between the OAA and FL antibody in both cell lines, with the top candidates highlighted. (D) (i) The top CDH17 candidates were paired with an anti-pCAD arm (generating BsAb 1-7) and compared to the corresponding CDH17 OAA and FL CDH17 arms. (ii) Internalization and proliferation inhibition assay in HT29 pCAD+CDH17+ treated with the three formats described in (i). (E) (i) FACS binding titration data of the 7 BsAbs in HT29 pCAD+ , HT29 CDH17+ HT29 pCAD+CDH17+ demonstrated that the BsAbs preferentially bind to dual expressing cells compared to CDH17+ cells. (ii) Fold change of the Amax of the BsAb binding curves between the pCAD+ and double positive cell or CDH17+ and double positive cell.
    Anti Pcad, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-pcad/product/Millipore
    Average 90 stars, based on 1 article reviews
    anti-pcad - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher p-cadherin pcad antibody
    a-e, See Table 1 for further descriptions. Representative IHC images showing key checkpoints throughout the differentiation procedure of WA25 hESC-derived skin organoids. a, Day 18 image representing the ECAD+TFAP2A+ epithelium and TFAP2A+ CNC or mesenchymal cells surrounding the aggregate; the presence of these cell populations should be checked between days 6–20 of differentiation. b, Day 55 images showing TFAP2A+KRT5+ and KRT17+KRT5+ basal layer, TFAP2A+ intermediate layer, and KRT17+ periderm layer; the periderm layer is detectable only at early stages of differentiation, prior to formation of the granular and cornified layers; the periderm layer is visible in organoids around days 40–75 of differentiation. c, Overall-view image of day 70 skin cysts; the images show the major layers of skin that are required to form the skin, the epidermal and the dermal layers, and the initiating hair germs; the basal layer of skin is highlighted by KRT5+KRT15+ and CD49f+ fluorescence signals; the periderm layer is visualized by KRT15; the dermal layer (fibroblasts) is visualized by PDGFRα, and NC cell-derived mesenchymal cells within the population express P75; the SOX2+ cells represent dermal condensates at the tip of the hair germs; the initial hair placode and germ formations can be observed starting around day 55 of differentiation. PD, periderm; DC, dermal condensate. d,e, Day 75 high-magnification images representing <t>PCAD+</t> hair placodes, PCAD+EDAR+LHX2+ hair germs, and PCAD+LHX2+ hair pegs; SOX2+ cells represent dermal condensates of hair germs and dermal papillae of hair pegs. f, A representative IHC image of a day 140 skin organoid. The endogenous green fluorescence from the DSP-GFP cell line visualizes epithelium of the skin cyst in the center and the hair follicles protruding from the surface of the cyst. TUJ1+ neurons are wrapping around and innervating the epithelium and the hair follicles. The skin organoids reach the lanugo-like mature stage around day 120 of differentiation. g, Representative darkfield images of a day 125 WA25 hESC-derived skin organoid (left) and dermal view of 18-week human fetal facial skin tissue (right). Skin organoids at days 120–140 resemble the mid-second trimester fetal skin tissue with (pigmented) hair follicles and adipocytes. h,i, Representative whole-mount immunostaining images of hair follicles with dermal papillae and melanocytes in a day 85 (h, left and middle) and a day 120 (i) WA25 hESC-derived skin organoids. KRT5 visualizes epithelium, outer root sheath (ORS) of hair follicles and newly forming hair germs (h, middle). SOX2 marks for melanocytes or Merkel cells present in the ORS of hair follicles and on the epithelium (h, right). MITF also specifies melanocytes in the ORS and on the epithelium. Dermal papillae of the hair follicles are also visualized by P75 (i). j, A representative whole-mount immunostaining image of a day 110 skin organoid hair follicles. The hair follicles contain a bulge region where KRT20+ touch-sensing Merkel cells are present. NEFH+ sensory neurons innervate the upper bulge region near Merkel cells. k, Representative brightfield images of plucked hairs from human fetal facial tissue at 18 weeks of gestation, adult male’s cheek (beard), skin organoid xenograft, and DSP skin organoid at day 190 of differentiation. Insets present a magnified area indicated with dash boxes. The medulla is only present in the adult beard. The medulla layer is not visible in xenograft hairs, either pigmented or non-pigmented. Darker hairs from a xenograft and a DSP skin organoid appear to contain pigmented cells that are scattered throughout the cortex, but no sign of medulla is detectable in the center of the hair shaft. See ref. 25 for additional images. The images are taken at the magnifications as follows: 200X (20X microscope objective × 10X eyepiece; b, d, e, h’); 100X (10X microscope objective × 10X eyepiece; a, c, h (left), i, and j); 50X (5X microscope objective × 10X eyepiece; g); 40X (4X microscope objective × 10X eyepiece; f and k (xenografts and organoid hairs)); 20X (2X microscope objective × 10X eyepiece; k (fetal hair and adult beard)). Scale bars, 500 μm (f, g, and k); 200 μm (a); 100 μm (b-e, and j); 50 μm (h (left) and i); 30 μm (h’).
    P Cadherin Pcad Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p-cadherin pcad antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    p-cadherin pcad antibody - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc 34000301 pcad cell signaling
    a-e, See Table 1 for further descriptions. Representative IHC images showing key checkpoints throughout the differentiation procedure of WA25 hESC-derived skin organoids. a, Day 18 image representing the ECAD+TFAP2A+ epithelium and TFAP2A+ CNC or mesenchymal cells surrounding the aggregate; the presence of these cell populations should be checked between days 6–20 of differentiation. b, Day 55 images showing TFAP2A+KRT5+ and KRT17+KRT5+ basal layer, TFAP2A+ intermediate layer, and KRT17+ periderm layer; the periderm layer is detectable only at early stages of differentiation, prior to formation of the granular and cornified layers; the periderm layer is visible in organoids around days 40–75 of differentiation. c, Overall-view image of day 70 skin cysts; the images show the major layers of skin that are required to form the skin, the epidermal and the dermal layers, and the initiating hair germs; the basal layer of skin is highlighted by KRT5+KRT15+ and CD49f+ fluorescence signals; the periderm layer is visualized by KRT15; the dermal layer (fibroblasts) is visualized by PDGFRα, and NC cell-derived mesenchymal cells within the population express P75; the SOX2+ cells represent dermal condensates at the tip of the hair germs; the initial hair placode and germ formations can be observed starting around day 55 of differentiation. PD, periderm; DC, dermal condensate. d,e, Day 75 high-magnification images representing <t>PCAD+</t> hair placodes, PCAD+EDAR+LHX2+ hair germs, and PCAD+LHX2+ hair pegs; SOX2+ cells represent dermal condensates of hair germs and dermal papillae of hair pegs. f, A representative IHC image of a day 140 skin organoid. The endogenous green fluorescence from the DSP-GFP cell line visualizes epithelium of the skin cyst in the center and the hair follicles protruding from the surface of the cyst. TUJ1+ neurons are wrapping around and innervating the epithelium and the hair follicles. The skin organoids reach the lanugo-like mature stage around day 120 of differentiation. g, Representative darkfield images of a day 125 WA25 hESC-derived skin organoid (left) and dermal view of 18-week human fetal facial skin tissue (right). Skin organoids at days 120–140 resemble the mid-second trimester fetal skin tissue with (pigmented) hair follicles and adipocytes. h,i, Representative whole-mount immunostaining images of hair follicles with dermal papillae and melanocytes in a day 85 (h, left and middle) and a day 120 (i) WA25 hESC-derived skin organoids. KRT5 visualizes epithelium, outer root sheath (ORS) of hair follicles and newly forming hair germs (h, middle). SOX2 marks for melanocytes or Merkel cells present in the ORS of hair follicles and on the epithelium (h, right). MITF also specifies melanocytes in the ORS and on the epithelium. Dermal papillae of the hair follicles are also visualized by P75 (i). j, A representative whole-mount immunostaining image of a day 110 skin organoid hair follicles. The hair follicles contain a bulge region where KRT20+ touch-sensing Merkel cells are present. NEFH+ sensory neurons innervate the upper bulge region near Merkel cells. k, Representative brightfield images of plucked hairs from human fetal facial tissue at 18 weeks of gestation, adult male’s cheek (beard), skin organoid xenograft, and DSP skin organoid at day 190 of differentiation. Insets present a magnified area indicated with dash boxes. The medulla is only present in the adult beard. The medulla layer is not visible in xenograft hairs, either pigmented or non-pigmented. Darker hairs from a xenograft and a DSP skin organoid appear to contain pigmented cells that are scattered throughout the cortex, but no sign of medulla is detectable in the center of the hair shaft. See ref. 25 for additional images. The images are taken at the magnifications as follows: 200X (20X microscope objective × 10X eyepiece; b, d, e, h’); 100X (10X microscope objective × 10X eyepiece; a, c, h (left), i, and j); 50X (5X microscope objective × 10X eyepiece; g); 40X (4X microscope objective × 10X eyepiece; f and k (xenografts and organoid hairs)); 20X (2X microscope objective × 10X eyepiece; k (fetal hair and adult beard)). Scale bars, 500 μm (f, g, and k); 200 μm (a); 100 μm (b-e, and j); 50 μm (h (left) and i); 30 μm (h’).
    34000301 Pcad Cell Signaling, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/34000301 pcad cell signaling/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    34000301 pcad cell signaling - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    Image Search Results


    (A) A schematic outlining the strategy for the identification of a lead pCAD x CDH17 BsAb. The first phase involves screening CDH17 monovalent and bivalent antibodies, and pairing the most avid CDH17 arm with a pCAD arm to evaluate potency and binding. The second phase involves screening a panel of pCAD alanine variants to identify the most avid pCAD arm, followed by pairing with the lead CDH17 arm. (B) One-armed antibody (OAA, monovalent) vs full-length antibody (FL, bivalent) internalization and growth inhibition results for the panel of CDH17 candidates in Snu16 and HT29 CDH17+ cell lines. A red dot indicates the top 7 CDH17 candidates. (C) The IC 50 fold changes between the OAA and FL antibody in both cell lines, with the top candidates highlighted. (D) (i) The top CDH17 candidates were paired with an anti-pCAD arm (generating BsAb 1-7) and compared to the corresponding CDH17 OAA and FL CDH17 arms. (ii) Internalization and proliferation inhibition assay in HT29 pCAD+CDH17+ treated with the three formats described in (i). (E) (i) FACS binding titration data of the 7 BsAbs in HT29 pCAD+ , HT29 CDH17+ HT29 pCAD+CDH17+ demonstrated that the BsAbs preferentially bind to dual expressing cells compared to CDH17+ cells. (ii) Fold change of the Amax of the BsAb binding curves between the pCAD+ and double positive cell or CDH17+ and double positive cell.

    Journal: bioRxiv

    Article Title: A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor specificity

    doi: 10.1101/2024.04.19.590291

    Figure Lengend Snippet: (A) A schematic outlining the strategy for the identification of a lead pCAD x CDH17 BsAb. The first phase involves screening CDH17 monovalent and bivalent antibodies, and pairing the most avid CDH17 arm with a pCAD arm to evaluate potency and binding. The second phase involves screening a panel of pCAD alanine variants to identify the most avid pCAD arm, followed by pairing with the lead CDH17 arm. (B) One-armed antibody (OAA, monovalent) vs full-length antibody (FL, bivalent) internalization and growth inhibition results for the panel of CDH17 candidates in Snu16 and HT29 CDH17+ cell lines. A red dot indicates the top 7 CDH17 candidates. (C) The IC 50 fold changes between the OAA and FL antibody in both cell lines, with the top candidates highlighted. (D) (i) The top CDH17 candidates were paired with an anti-pCAD arm (generating BsAb 1-7) and compared to the corresponding CDH17 OAA and FL CDH17 arms. (ii) Internalization and proliferation inhibition assay in HT29 pCAD+CDH17+ treated with the three formats described in (i). (E) (i) FACS binding titration data of the 7 BsAbs in HT29 pCAD+ , HT29 CDH17+ HT29 pCAD+CDH17+ demonstrated that the BsAbs preferentially bind to dual expressing cells compared to CDH17+ cells. (ii) Fold change of the Amax of the BsAb binding curves between the pCAD+ and double positive cell or CDH17+ and double positive cell.

    Article Snippet: Other antibodies used in this study were purchased from commercial vendors: Alexa Fluor® 647 AffiniPure Goat Anti-Human IgG (H+L) (Jackson), anti-CDH17 (abcam 109190), anti-pCAD (Sigma HPA001767).

    Techniques: Binding Assay, Inhibition, Titration, Expressing

    (A) Representation of systematic alanine scanning of the light chain CDR3 to generate 8 alanine variants. (B) Internalization and proliferation inhibition assay performed using the HT29 pCAD+ cell line treated with OAA pCAD alanine variants, and the control pCAD mAb (OAA and FL). Highlighted dots represent the 3 pCAD alanine variants that were selected for further investigation. (C) (i) FACS binding titration assay using the HT29 pCAD+ cell line treated with OAA pCAD alanine variants, and the control pCAD mAb OAA. The 3 pCAD alanine variants selected are highlighted. (ii) Fold change of the IC 50 s between the pCAD alanine variants and parental pCAD. (D) Internalization and proliferation inhibition assay performed on a panel of HT29 cell lines treated with (i) the parental pCAD mAb x lead CDH17 bsAb (bsAb5), and (ii) the 3 pCAD alanine variants shuffled with the lead CDH17 arm (bsAb 8, 9, and 10). (iii) IC50 and Amax values and (iv) the IC 50 fold change between inhibition of pCAD only and dual expressing cells, and CDH17 only and dual expressing cells, upon treatment with pCAD x CDH17 bsAbs.

    Journal: bioRxiv

    Article Title: A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor specificity

    doi: 10.1101/2024.04.19.590291

    Figure Lengend Snippet: (A) Representation of systematic alanine scanning of the light chain CDR3 to generate 8 alanine variants. (B) Internalization and proliferation inhibition assay performed using the HT29 pCAD+ cell line treated with OAA pCAD alanine variants, and the control pCAD mAb (OAA and FL). Highlighted dots represent the 3 pCAD alanine variants that were selected for further investigation. (C) (i) FACS binding titration assay using the HT29 pCAD+ cell line treated with OAA pCAD alanine variants, and the control pCAD mAb OAA. The 3 pCAD alanine variants selected are highlighted. (ii) Fold change of the IC 50 s between the pCAD alanine variants and parental pCAD. (D) Internalization and proliferation inhibition assay performed on a panel of HT29 cell lines treated with (i) the parental pCAD mAb x lead CDH17 bsAb (bsAb5), and (ii) the 3 pCAD alanine variants shuffled with the lead CDH17 arm (bsAb 8, 9, and 10). (iii) IC50 and Amax values and (iv) the IC 50 fold change between inhibition of pCAD only and dual expressing cells, and CDH17 only and dual expressing cells, upon treatment with pCAD x CDH17 bsAbs.

    Article Snippet: Other antibodies used in this study were purchased from commercial vendors: Alexa Fluor® 647 AffiniPure Goat Anti-Human IgG (H+L) (Jackson), anti-CDH17 (abcam 109190), anti-pCAD (Sigma HPA001767).

    Techniques: Inhibition, Binding Assay, Titration, Expressing

    (A) Schematic of the two dual flank cell line-derived xenograft models used in these studies: (i) CDH17 dual flank model and (ii) pCAD dual flank model. (B) Treatment response in (i) CDH17 and (ii) pCAD dual flank models treated with the parental pCAD x CDH17 (bsAb 5) MMAE ADC at 2.5 mpk. Dotted lines represent vehicle treatment and solid lines represent treatment with the bsAb ADC. (C) Treatment response in both models as performed in (B), with the lead pCAD x CDH17 (bsAb 10) MMAE ADC at 2.5 mpk.

    Journal: bioRxiv

    Article Title: A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor specificity

    doi: 10.1101/2024.04.19.590291

    Figure Lengend Snippet: (A) Schematic of the two dual flank cell line-derived xenograft models used in these studies: (i) CDH17 dual flank model and (ii) pCAD dual flank model. (B) Treatment response in (i) CDH17 and (ii) pCAD dual flank models treated with the parental pCAD x CDH17 (bsAb 5) MMAE ADC at 2.5 mpk. Dotted lines represent vehicle treatment and solid lines represent treatment with the bsAb ADC. (C) Treatment response in both models as performed in (B), with the lead pCAD x CDH17 (bsAb 10) MMAE ADC at 2.5 mpk.

    Article Snippet: Other antibodies used in this study were purchased from commercial vendors: Alexa Fluor® 647 AffiniPure Goat Anti-Human IgG (H+L) (Jackson), anti-CDH17 (abcam 109190), anti-pCAD (Sigma HPA001767).

    Techniques: Derivative Assay

    a-e, See Table 1 for further descriptions. Representative IHC images showing key checkpoints throughout the differentiation procedure of WA25 hESC-derived skin organoids. a, Day 18 image representing the ECAD+TFAP2A+ epithelium and TFAP2A+ CNC or mesenchymal cells surrounding the aggregate; the presence of these cell populations should be checked between days 6–20 of differentiation. b, Day 55 images showing TFAP2A+KRT5+ and KRT17+KRT5+ basal layer, TFAP2A+ intermediate layer, and KRT17+ periderm layer; the periderm layer is detectable only at early stages of differentiation, prior to formation of the granular and cornified layers; the periderm layer is visible in organoids around days 40–75 of differentiation. c, Overall-view image of day 70 skin cysts; the images show the major layers of skin that are required to form the skin, the epidermal and the dermal layers, and the initiating hair germs; the basal layer of skin is highlighted by KRT5+KRT15+ and CD49f+ fluorescence signals; the periderm layer is visualized by KRT15; the dermal layer (fibroblasts) is visualized by PDGFRα, and NC cell-derived mesenchymal cells within the population express P75; the SOX2+ cells represent dermal condensates at the tip of the hair germs; the initial hair placode and germ formations can be observed starting around day 55 of differentiation. PD, periderm; DC, dermal condensate. d,e, Day 75 high-magnification images representing PCAD+ hair placodes, PCAD+EDAR+LHX2+ hair germs, and PCAD+LHX2+ hair pegs; SOX2+ cells represent dermal condensates of hair germs and dermal papillae of hair pegs. f, A representative IHC image of a day 140 skin organoid. The endogenous green fluorescence from the DSP-GFP cell line visualizes epithelium of the skin cyst in the center and the hair follicles protruding from the surface of the cyst. TUJ1+ neurons are wrapping around and innervating the epithelium and the hair follicles. The skin organoids reach the lanugo-like mature stage around day 120 of differentiation. g, Representative darkfield images of a day 125 WA25 hESC-derived skin organoid (left) and dermal view of 18-week human fetal facial skin tissue (right). Skin organoids at days 120–140 resemble the mid-second trimester fetal skin tissue with (pigmented) hair follicles and adipocytes. h,i, Representative whole-mount immunostaining images of hair follicles with dermal papillae and melanocytes in a day 85 (h, left and middle) and a day 120 (i) WA25 hESC-derived skin organoids. KRT5 visualizes epithelium, outer root sheath (ORS) of hair follicles and newly forming hair germs (h, middle). SOX2 marks for melanocytes or Merkel cells present in the ORS of hair follicles and on the epithelium (h, right). MITF also specifies melanocytes in the ORS and on the epithelium. Dermal papillae of the hair follicles are also visualized by P75 (i). j, A representative whole-mount immunostaining image of a day 110 skin organoid hair follicles. The hair follicles contain a bulge region where KRT20+ touch-sensing Merkel cells are present. NEFH+ sensory neurons innervate the upper bulge region near Merkel cells. k, Representative brightfield images of plucked hairs from human fetal facial tissue at 18 weeks of gestation, adult male’s cheek (beard), skin organoid xenograft, and DSP skin organoid at day 190 of differentiation. Insets present a magnified area indicated with dash boxes. The medulla is only present in the adult beard. The medulla layer is not visible in xenograft hairs, either pigmented or non-pigmented. Darker hairs from a xenograft and a DSP skin organoid appear to contain pigmented cells that are scattered throughout the cortex, but no sign of medulla is detectable in the center of the hair shaft. See ref. 25 for additional images. The images are taken at the magnifications as follows: 200X (20X microscope objective × 10X eyepiece; b, d, e, h’); 100X (10X microscope objective × 10X eyepiece; a, c, h (left), i, and j); 50X (5X microscope objective × 10X eyepiece; g); 40X (4X microscope objective × 10X eyepiece; f and k (xenografts and organoid hairs)); 20X (2X microscope objective × 10X eyepiece; k (fetal hair and adult beard)). Scale bars, 500 μm (f, g, and k); 200 μm (a); 100 μm (b-e, and j); 50 μm (h (left) and i); 30 μm (h’).

    Journal: Nature protocols

    Article Title: Generation and characterization of hair-bearing skin organoids from human pluripotent stem cells

    doi: 10.1038/s41596-022-00681-y

    Figure Lengend Snippet: a-e, See Table 1 for further descriptions. Representative IHC images showing key checkpoints throughout the differentiation procedure of WA25 hESC-derived skin organoids. a, Day 18 image representing the ECAD+TFAP2A+ epithelium and TFAP2A+ CNC or mesenchymal cells surrounding the aggregate; the presence of these cell populations should be checked between days 6–20 of differentiation. b, Day 55 images showing TFAP2A+KRT5+ and KRT17+KRT5+ basal layer, TFAP2A+ intermediate layer, and KRT17+ periderm layer; the periderm layer is detectable only at early stages of differentiation, prior to formation of the granular and cornified layers; the periderm layer is visible in organoids around days 40–75 of differentiation. c, Overall-view image of day 70 skin cysts; the images show the major layers of skin that are required to form the skin, the epidermal and the dermal layers, and the initiating hair germs; the basal layer of skin is highlighted by KRT5+KRT15+ and CD49f+ fluorescence signals; the periderm layer is visualized by KRT15; the dermal layer (fibroblasts) is visualized by PDGFRα, and NC cell-derived mesenchymal cells within the population express P75; the SOX2+ cells represent dermal condensates at the tip of the hair germs; the initial hair placode and germ formations can be observed starting around day 55 of differentiation. PD, periderm; DC, dermal condensate. d,e, Day 75 high-magnification images representing PCAD+ hair placodes, PCAD+EDAR+LHX2+ hair germs, and PCAD+LHX2+ hair pegs; SOX2+ cells represent dermal condensates of hair germs and dermal papillae of hair pegs. f, A representative IHC image of a day 140 skin organoid. The endogenous green fluorescence from the DSP-GFP cell line visualizes epithelium of the skin cyst in the center and the hair follicles protruding from the surface of the cyst. TUJ1+ neurons are wrapping around and innervating the epithelium and the hair follicles. The skin organoids reach the lanugo-like mature stage around day 120 of differentiation. g, Representative darkfield images of a day 125 WA25 hESC-derived skin organoid (left) and dermal view of 18-week human fetal facial skin tissue (right). Skin organoids at days 120–140 resemble the mid-second trimester fetal skin tissue with (pigmented) hair follicles and adipocytes. h,i, Representative whole-mount immunostaining images of hair follicles with dermal papillae and melanocytes in a day 85 (h, left and middle) and a day 120 (i) WA25 hESC-derived skin organoids. KRT5 visualizes epithelium, outer root sheath (ORS) of hair follicles and newly forming hair germs (h, middle). SOX2 marks for melanocytes or Merkel cells present in the ORS of hair follicles and on the epithelium (h, right). MITF also specifies melanocytes in the ORS and on the epithelium. Dermal papillae of the hair follicles are also visualized by P75 (i). j, A representative whole-mount immunostaining image of a day 110 skin organoid hair follicles. The hair follicles contain a bulge region where KRT20+ touch-sensing Merkel cells are present. NEFH+ sensory neurons innervate the upper bulge region near Merkel cells. k, Representative brightfield images of plucked hairs from human fetal facial tissue at 18 weeks of gestation, adult male’s cheek (beard), skin organoid xenograft, and DSP skin organoid at day 190 of differentiation. Insets present a magnified area indicated with dash boxes. The medulla is only present in the adult beard. The medulla layer is not visible in xenograft hairs, either pigmented or non-pigmented. Darker hairs from a xenograft and a DSP skin organoid appear to contain pigmented cells that are scattered throughout the cortex, but no sign of medulla is detectable in the center of the hair shaft. See ref. 25 for additional images. The images are taken at the magnifications as follows: 200X (20X microscope objective × 10X eyepiece; b, d, e, h’); 100X (10X microscope objective × 10X eyepiece; a, c, h (left), i, and j); 50X (5X microscope objective × 10X eyepiece; g); 40X (4X microscope objective × 10X eyepiece; f and k (xenografts and organoid hairs)); 20X (2X microscope objective × 10X eyepiece; k (fetal hair and adult beard)). Scale bars, 500 μm (f, g, and k); 200 μm (a); 100 μm (b-e, and j); 50 μm (h (left) and i); 30 μm (h’).

    Article Snippet: P-cadherin (PCAD) , Thermo Fisher Scientific , 32-4000 , AB_2533077 https://scicrunch.org/resolver/RRID:AB_2533077 , Mouse , IgG 1 , 1:50 , Hair placodes, germs, and pegs.

    Techniques: Derivative Assay, Fluorescence, Immunostaining, Microscopy

    Major checkpoints

    Journal: Nature protocols

    Article Title: Generation and characterization of hair-bearing skin organoids from human pluripotent stem cells

    doi: 10.1038/s41596-022-00681-y

    Figure Lengend Snippet: Major checkpoints

    Article Snippet: P-cadherin (PCAD) , Thermo Fisher Scientific , 32-4000 , AB_2533077 https://scicrunch.org/resolver/RRID:AB_2533077 , Mouse , IgG 1 , 1:50 , Hair placodes, germs, and pegs.

    Techniques: Imaging

    Primary antibodies

    Journal: Nature protocols

    Article Title: Generation and characterization of hair-bearing skin organoids from human pluripotent stem cells

    doi: 10.1038/s41596-022-00681-y

    Figure Lengend Snippet: Primary antibodies

    Article Snippet: P-cadherin (PCAD) , Thermo Fisher Scientific , 32-4000 , AB_2533077 https://scicrunch.org/resolver/RRID:AB_2533077 , Mouse , IgG 1 , 1:50 , Hair placodes, germs, and pegs.

    Techniques: Isotope Dilution, Marker